Company intelligence / Profile preview

Allied Research International

Toronto, Ontario, Canadaca.linkedin.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Allied Research International was an international contract research organization providing clinical trial management and related services to the pharmaceutical and biotechnology industries. The company supported at least three clinical trials, including studies in infectious disease such as chikungunya arthritis. There is no evidence of current active operations or recent news after early 2020s.

Therapeutic areas: Infectious Diseases
Industry: Contract Research Organization

Drug pipeline

3 assets

fentanyl

Phase 3

Indications: Breakthrough cancer pain

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Allied Research International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allied Research International.

Explore the full profile